Cancer and COVID-19

Related articles:

26.01.2022

A study of a nasal vaccine against COVID-19 started in Moscow

A clinical trial of the nasal vaccine against COVID-19 Sputnik has begun in Moscow. 400 volunteers will participate in the first two phases, the first of them have already been vaccinated.

26.01.2022

Government allocated more than 20 billion rubles for medicines for COVID-19

Over 15 billion rubles will be allocated to medications not registered in Russia for the treatment of patients in hospitals - the authorities will purchase 200 thousand packages of molnupiravir and 78,456 packages of thixagevimab + cilgavimab, as well as about 3.1 thousand bottles of sotrovimab and approximately 515 thousand packages of remdesivir.

26.01.2022

Coronavirus quarantine for contact persons reduced to seven days

The quarantine period for people who have been in contact with COVID-19 persons has been reduced from two weeks to seven days. The resolution on this was adopted by the chief state sanitary doctor.

26.07.2021

COVID-19 vaccination recommendations for cancer patients

The Ministry of Health of Russia issued updated recommendations for Covid-19 vaccination.
The Gam-COVID-Vac vaccine (Sputnik V) for prevention of COVID-19 is recommended without additional restrictions for all cancer patients who have completed antitumor treatment, regardless of the initial stage and form of the disease. According to the recommendations, vaccination should be carried out no later than 14 days before the start of a surgical operation, if it is planned.

astrazeneca
olympus
philips
amteo
Ирвин 2
sanofi
roche
Р-ФАРМ
АМИ
sotio
novartis
exactsciences
takeda
bms